An algorithm to generate correlated input-parameters to be used in probabilistic sensitivity analyses by Mohamed Neine, Desmond Curran

Get full text

Cost-effectiveness of the recombinant zoster vaccine (RZV) against herpes zoster: An updated critical review by Nikolaos Giannelos, Cheryl Ng, Desmond Curran

Get full text

Patient-reported outcomes in vaccines research: relevance for decision-making by Desmond Curran, Eliazar Sabater Cabrera, Linda Nelsen

Get full text

Herpes zoster in older adults: Impact on carbon footprint in the United States by Desmond Curran, Jacopo Bitetti, Imogen Catterall, Stephen Wincott

Get full text

The Impact of the COVID-19 Pandemic on the Incidence of Herpes Zoster: A Narrative Literature Review by Raunak Parikh, Mitra Yousefi, Desmond Curran, Robyn Widenmaier

Get full text

Healthy ageing: Herpes zoster infection and the role of zoster vaccination by Desmond Curran, T. Mark Doherty, Nicolas Lecrenier, Thomas Breuer

Get full text

Modelled Public Health Impact of Introducing Adjuvanted Recombinant Zoster Vaccine into the UK National Immunisation Programme by Manjit Hunjan, Desmond Curran, Alen Marijam, Yasmeeta Vekria, Nikolaos Giannelos

Get full text

Recombinant zoster vaccine in immunocompetent and immunocompromised adults: A review of clinical studies by Agnes Mwakingwe-Omari, Nicolas Lecrenier, Abdi Naficy, Desmond Curran, Inga Posiuniene

Get full text

Potential public health impact of the adjuvanted recombinant zoster vaccine among people aged 50 years and older in Beijing by Christa Lee, Ning Jiang, Haiwen Tang, Chiyu Ye, Yanfei Yuan, Desmond Curran

Get full text

The Incidence of Herpes Zoster Complications: A Systematic Literature Review by Nikolaos Giannelos, Desmond Curran, Chi Nguyen, Carol Kagia, Nikki Vroom, Hilde Vroling

Get full text

Modeled impact of the COVID-19 pandemic and associated reduction in adult vaccinations on herpes zoster in the United States by Desmond Curran, Elizabeth M. La, Ahmed Salem, David Singer, Nicolas Lecrenier, Sara Poston

Get full text

Herpes zoster related healthcare burden and costs in immunocompromised (IC) and IC-free populations in England: an observational retrospective database analysis by Manjit Hunjan, Desmond Curran, Amale El Ghachi, Yassine El-Hahi, Veronique Bianco, Germano Ferreira

Get full text

Long-term efficacy data for the recombinant zoster vaccine: impact on public health and cost effectiveness in Germany by Desmond Curran, Desirée Van Oorschot, Sean Matthews, Johannes Hain, Ahmed Ehab Salem, Magdalena Schwarz

Get full text

A systematic literature review of herpes zoster incidence worldwide by Désirée van Oorschot, Hilde Vroling, Eveline Bunge, John Diaz-Decaro, Desmond Curran, Barbara Yawn

Get full text

Should adults with diabetes mellitus be vaccinated against hepatitis B virus? A systematic review of diabetes mellitus and the progression of hepatitis B disease by Zobair Younossi, Katrin Kochems, Marc de Ridder, Desmond Curran, Eveline M. Bunge, Laurence de Moerlooze

Get full text

Cost-effectiveness of the adjuvanted RSVPreF3 vaccine among adults aged ≥60 years in the United States by Elizabeth M. La, Jonathan Graham, David Singer, Daniel Molnar, Sara Poston, Desmond Curran, Jessica Pickett, Frederik Verelst

Get full text

Public Health Impact of the Adjuvanted RSVPreF3 Vaccine for Respiratory Syncytial Virus Prevention Among Older Adults in the United States by Daniel Molnar, Elizabeth M. La, Frederik Verelst, Sara Poston, Jonathan Graham, Laure-Anne Van Bellinghen, Desmond Curran

Get full text

Assessment of the potential public health impact of Herpes Zoster vaccination in Germany by Desmond Curran, Desirée Van Oorschot, Lijoy Varghese, Lidia Oostvogels, Tomas Mrkvan, Romulo Colindres, Alfred von Krempelhuber, Anastassia Anastassopoulou

Get full text

Lifetime risk of herpes zoster in the population of Beijing, China by Christa Lee, Nikolaos Giannelos, Desmond Curran, Hengjin Dong, Haiwen Tang, Ning Jiang, Chiyu Ye, Yanfei Yuan, Cheryl Ng

Get full text

Cost-effectiveness of the recombinant zoster vaccine in the German population aged ≥60 years old by Desirée Van Oorschot, Anastassia Anastassopoulou, Barbara Poulsen Nautrup, Lijoy Varghese, Alfred von Krempelhuber, Mohamed Neine, Stéphane Lorenc, Desmond Curran

Get full text